Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 PLEXXIKON INC., Case No. 17-cv-04405-HSG Plaintiff, 8 ORDER DENYING DEFENDANT'S 9 v. MOTION FOR SUMMARY JUDGMENT 10 NOVARTIS PHARMACEUTICALS CORPORATION, Re: Dkt. No. 177 11 Defendant. 12 13 Pending before the Court is Defendant Novartis Pharmaceuticals Corporation’s motion for 14 partial summary judgment that certain claims of U.S. Patent Nos. 9,469,640 (the “’640 Patent”) 15 and 9,844,539 (the “’539 Patent”) (together, the “Asserted Patents”) are invalid as anticipated 16 under

35 U.S.C. § 102.1

The dispute, as briefed…